Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma. Matoba Y, Zarrella DT, Pooladanda V, Azimi Mohammadabadi M, et al. Br J Cancer 2024 Mar 4. doi: 10.1038/s41416-024-02621.

Read + Share

Amedeo Smart

Independent Medical Education

Matoba Y, Zarrella DT, Pooladanda V, Azimi Mohammadabadi M, et al. Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma. Br J Cancer 2024 Mar 4. doi: 10.1038/s41416-024-02621.
PMID: 38438589